These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15647290)

  • 1. Making sense of SENIORS.
    McMurray J
    Eur Heart J; 2005 Feb; 26(3):203-6. PubMed ID: 15647290
    [No Abstract]   [Full Text] [Related]  

  • 2. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 3. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too].
    MMW Fortschr Med; 2003 May; 145(22):55. PubMed ID: 12866284
    [No Abstract]   [Full Text] [Related]  

  • 4. Nebivolol: new indication. Heart failure: 'me-too' available in single dose strength only. Select better-assessed betablockers.
    Prescrire Int; 2007 Dec; 16(92):235. PubMed ID: 18087800
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
    Shibata MC; Flather MD; Böhm M; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Parkhomenko A; Soler-Soler J; Tavazzi L; Toman J; Van Veldhuisen DJ; Coats AJ; Poole-Wilson P;
    Int J Cardiol; 2002 Nov; 86(1):77-85. PubMed ID: 12243852
    [No Abstract]   [Full Text] [Related]  

  • 6. β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
    Ambrosio G; Flather MD; Böhm M; Cohen-Solal A; Murrone A; Mascagni F; Spinucci G; Conti MG; van Veldhuisen DJ; Tavazzi L; Coats AJ
    Heart; 2011 Feb; 97(3):209-14. PubMed ID: 21138861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of Nebivolol in the treatment of chronic heart failure.
    Liberopoulos EN; Elisaf MS
    Hellenic J Cardiol; 2005; 46(3):208-11. PubMed ID: 15981556
    [No Abstract]   [Full Text] [Related]  

  • 8. Nebivolol for heart failure in the elderly.
    Tavazzi L
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):423-33. PubMed ID: 17489667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
    MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603611
    [No Abstract]   [Full Text] [Related]  

  • 10. Nebivolol in chronic heart failure: current evidence and future perspectives.
    Lipsic E; van Veldhuisen DJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):983-92. PubMed ID: 20307222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta blocker in endothelial dysfunction. Growth of blood vessel cells is halted].
    MMW Fortschr Med; 2002 Aug; 144(33-34):56. PubMed ID: 12380150
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial.
    Cleland JG; Huan Loh P; Freemantle N; Clark AL; Coletta AP
    Eur J Heart Fail; 2004 Oct; 6(6):787-91. PubMed ID: 15542417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does nebivolol improve endothelial dysfunction and will it rescue the reputation of the beta-blockers in the future?
    Celik T; Iyisoy A
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):388-9. PubMed ID: 18065334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta blockade plus NO release. Patients with heart failure can be loaded more].
    MMW Fortschr Med; 2002 Oct; 144(41):57. PubMed ID: 12474368
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
    Sarafidis PA; Bakris GL
    J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heart and lung disease. Are beta blockers allowed in asthma?].
    MMW Fortschr Med; 2001 May; 143(21):58. PubMed ID: 11420835
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of sinus rhythm predicts readmission, not Beta blockade.
    McCulloch AC
    Am J Cardiol; 2010 May; 105(9):1358. PubMed ID: 20403494
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol: new therapy update.
    Sule SS; Frishman W
    Cardiol Rev; 2006; 14(5):259-64. PubMed ID: 16924166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.